Immunogenicity and protective efficacy of a tuberculosis DNA vaccineKris Huygen, Jeffrey B. Ulmer, Jean Content et al.|Nature Medicine|1996Cited by 632
Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutininStéphane Temmerman, Camille Locht, Kévin Pethe et al.|Nature Medicine|2004Cited by 144
CORRELATION AND PROGNOSTIC SIGNIFICANCE OF p53, p21 <sup>WAF1/CIP1</sup> AND Ki-67 EXPRESSION IN PATIENTS WITH SUPERFICIAL BLADDER TUMORS TREATED WITH BACILLUS CALMETTE-GUERIN INTRAVESICAL THERAPYAlexandre R. Zlotta, Claude C. Schulman, Jean‐Christophe Noël et al.|The Journal of Urology|1999Cited by 124
Differential T and B Cell Responses against<i>Mycobacterium tuberculosis</i>Heparin‐Binding Hemagglutinin Adhesin in Infected Healthy Individuals and Patients with TuberculosisChantal Masungi, Françoise Mascart, Stéphane Temmerman et al.|The Journal of Infectious Diseases|2002Cited by 115
T Cell Reactivity against Mycolyl Transferase Antigen 85 of<i>M. tuberculosis</i>in HIV-TB Coinfected Subjects and in AIDS Patients Suffering from Tuberculosis and Nontuberculous Mycobacterial InfectionsPascal Launois, Kris Huygen, Annie Drowart et al.|Clinical and Developmental Immunology|2010Cited by 112